LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global contrast injectors market since 2015 and the market is poised to grow by USD 613.47 million during 2020-2024, progressing at a CAGR of ...
The Max 3 ™ injector is the first and only syringeless MRI injector available on the U.S. market. It is engineered for precise, efficient, and hygienic contrast delivery. The system simplifies MRI ...
Follows recent FDA clearance to expand the use of compatible contrast agent presentations, adding single-dose vials in addition to Imaging Bulk Package presentations Radiology suites now have the ...
Please provide your email address to receive an email when new articles are posted on . New data from the AVERT trial demonstrate that use of a manual contrast modulation system during coronary ...
The FDA has granted expanded indications for use of gadobutrol (Gadavist; Bayer) injection, permitting its use in cardiac MR to assess myocardial perfusion and late gadolinium enhancement in adults ...
Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...
PRINCETON, N.J., Nov. 25, 2025 /PRNewswire/ -- Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leader in diagnostic imaging, announced today that the U.S. Food and Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results